TG THERAPEUTICS, INC.: net_income
| Value | {"amount": 23383000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | superseded |
| Entity | TG THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:42:11.974157+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/a8606b34-826c-4def-8fb0-315451cd9196
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001437749-25-005908Retrieved: 2026-08-19T09:42:11.974157+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001001316/net-income/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/a8606b34-826c-4def-8fb0-315451cd9196
History
- no predecessors — first report